Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

Tokyo Big Sight

Oct 19, 2025 9:30 AM - Oct 21, 2025 6:00 PM

3-11-1 Ariake, Koto-ku, Tokyo, 135-0063 Japan

The 22nd DIA Japan Annual Meeting 2025

Strong Ties of Japan with Asia and the World for Delivering ‘Tomorrow's Normal’ to Patients

Overview

Click Here to View the Flyer


The 22nd DIA Japan Annual Meeting 2025 will be held at Tokyo Big-Sight from October 19 to October 21, 2025.

The theme of this meeting is "Strong Ties of Japan with Asia and the World for Delivering ‘Tomorrow's Normal’ to Patients." With the globalization of medical care, including recent progress in the use of AI/digital technology for building more efficient ecosystems and processes worldwide, the environment surrounding the development and pharmacovigilance of drugs and other medical products is rapidly changing. In these circumstances, the Asian region plays a major role in the advancement of healthcare systems around the world, and further collaboration among Japan, Asia, and the world will promote medical innovation and provide innovative medical products to patients.


This year's meeting offers an opportunity for all local and global stakeholders who are considering the future of medical care to strengthen their partnerships, including cross-border cooperation, to promote innovation and advance medical care by sharing their knowledge and experiences. At this meeting, we will collaborate together to create “Tomorrow’s Normal” in which everyone can feel peaceful and lead vibrant and healthy lives.

This year’s meeting has also established an English-language track to enable more globally interactive sessions with local and overseas experts, generate active discussions on ways to further advance medical innovation through sharing the latest knowledge on the current medical product development and post-marketing environments, and strengthen cooperation among Japan, Asia, and the world.


We invite you to share your knowledge and experience at the 22nd DIA Japan Annual Meeting 2025 so that we can think together about “Delivering ‘Tomorrow’s Normal’ to Patients,” and sincerely look forward to your active participation.

 

Program Committee

  • Yasuhiro  Fujiwara, MD, PhD
    Yasuhiro Fujiwara, MD, PhD Chief Executive
    Pharmaceuticals and Medical Devices Agency (PMDA), Japan
  • Keiko  Tsumori, MSc
    Keiko Tsumori, MSc Associate Director, Medical Writing, Regulatory Affairs Area, Japan Development
    MSD K.K., Japan
  • Yoshiaki  Uyama, PhD, MS, RPh
    Yoshiaki Uyama, PhD, MS, RPh Associate Executive Director
    Pharmaceuticals and Medical Devices Agency (PMDA), Japan
  • Asami  Ezaki, MS
    Asami Ezaki, MS Division Director, PR Section, Office of Planning and Operations
    Pharmaceuticals and Medeical Devices Agency (PMDA), Japan
  • Hiroya  Nakamura
    Hiroya Nakamura Employee
    Pharmaceuticals and Medical Devices Agency, Japan
  • Yuko  Hata
    Yuko Hata Associate director, Therapeutic Area Regulatory, Japan Regulatory Affairs
    Takeda Pharmaceutical Company, Japan
  • Masaaki  Jitsu
    Masaaki Jitsu
    Bayer Yakuhin Ltd, Japan
  • Yuki  Kai, MBA
    Yuki Kai, MBA Clinical Strategy and Resource Management Department, Clinical Development Divis
    Chugai Pharmaceutical Co., Ltd.,, Japan
  • Yusuke  Kajimoto
    Yusuke Kajimoto Senior Scientist, Scientific Affairs
    MSD K.K., Japan
  • Tomoyuki  Kakizume, PhD
    Tomoyuki Kakizume, PhD
    Daiichi Sankyo Co., Ltd., Japan
  • Keiko  Katsui, PhD
    Keiko Katsui, PhD Group of Social Co-Creation
    Japan Agency for Medical Research and Development (AMED), Japan
  • Kentaro  Kogushi, PhD
    Kentaro Kogushi, PhD Head of Clinical Development Neurology-Psychiatry, Japan Development
    AbbVie GK, Japan
  • Yuko  Kojima, RPh
    Yuko Kojima, RPh Sr. Executive Director
    Eli Lilly Japan K.K., Japan
  • Yu  Komura
    Yu Komura Study Manager, Clinical Research Support Office
    National Cancer Center Hospital East, Japan
  • Naoki  Kotani, PhD
    Naoki Kotani, PhD Pharmaceutical Science Dept.
    Chugai Pharmaceutical Co., Ltd., Japan
  • Ayaka  Kubota
    Ayaka Kubota Office of Safty II
    Pharmaceuticals and Medical Devices Agency (PMDA), Japan
  • Misato  Kuwagaki, MS
    Misato Kuwagaki, MS Associate Director, Data Sciences
    Eli Lilly Japan K.K., Japan
  • Yukiko  Nishimura, PhD, MSc
    Yukiko Nishimura, PhD, MSc Director
    Advocacy Service for Rare and Intractable Diseases, Japan
  • Fumitaka  Noji
    Fumitaka Noji Asscociate Director, Clinical Operations (Therapeutics and Oncology)
    Moderna Japan Co., Ltd., Japan
  • Kumiko  Okada
    Kumiko Okada Study Manager, Clinical Operations
    Pfizer R&D, Japan
  • Ai  Okazaki, MT
    Ai Okazaki, MT Health Science Research & Development Center
    Institute of Science Tokyo Hospital, Japan
  • Goshi  Ozawa, MS
    Goshi Ozawa, MS CEO
    Real Discovery Outdorrs K.K., Japan
  • Mikiko  Shitara
    Mikiko Shitara Senior Manager, Regulatory Affairs Dept.
    Alexionpharma GK, Japan
  • Keisuke  Suzuki, PhD
    Keisuke Suzuki, PhD Director, Innovation Center for Translational Research
    National Center for Geriatrics and Gerontology, Japan
  • Tadashi  Urashima, PhD
    Tadashi Urashima, PhD Performance and Digital Analytics Lead, Japan Development
    GlaxoSmithKline K.K., Japan
  • Hiroto  Asou
    Hiroto Asou Reviewer, Office of New Drug IV
    Pharmaceuticals and Medical Devices Agency (PMDA), Japan
  • Koichi  GOTO
    Koichi GOTO Deputy Manager
    CM Plus Corporation, Japan
  • Eri  Matsunaga
    Eri Matsunaga R&D Quality Group, R&D & PV Quality Assurance Department
    Daiichi Sankyo Co., Ltd., Japan
  • Futaba  Nagata
    Futaba Nagata
    PPG Service, Japan
  • Noriaki  Okada
    Noriaki Okada Clinical Operations
    Eisai Co., Ltd., Japan
  • Maki  Yoro
    Maki Yoro Office of Informatics and Management for Safety
    Pharmaceuticals and Medical Devices Agency (PMDA), Japan
  • Kanji  Hirai, RPh
    Kanji Hirai, RPh Director, Regulatory Policy & Intelligence, Regulatory Affair Area, Japan Dvlpmt
    MSD K.K., Japan
  • Noriaki  Nagao, MPharm, PMP
    Noriaki Nagao, MPharm, PMP Pharmaceutical Division,Clinical Development Dept.
    JAPAN TOBACCO INC., Japan
  • Mitsuhiro  Niimi, PhD
    Mitsuhiro Niimi, PhD Vice President & Managing Director, Japan
    DIA, Japan

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.